GlassScriptPhysician profile
Peter Thomas Sylvester
NPI 1538574538
$11,522.05
in general payments reported to CMS, 2019-2025
27 companies · $1,499 in 2025
The $1,499 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,994 · 2020: $33.31 · 2021: $1,045 · 2022: $2,798 · 2023: $662 · 2024: $491 · 2025: $1,499.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,832 · Travel and Lodging: $820.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,832.10 |
| Travel and Lodging | $819.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alphatec Spine, INC | $2,408.07 | 2021-2022 | |
| Medtronic, INC. | $2,251.65 | 2021-2025 | Cd Horizon Spinal System, Intellis Adaptivestim, Catalyft Pl Expandable Interbody System |
| Stryker Corporation | $2,167.77 | 2019-2025 | Colorado, Adherus Autospray Et Dural Sealant, Na |
| Aesculap, INC. | $1,959.27 | 2019-2025 | Aesculap |
| Medtronic USA, INC. | $930.76 | 2019-2020 | |
| Abbott Laboratories | $425.29 | 2021-2025 | Eterna |
| Centinel Spine, LLC | $231.87 | 2023 | Prodisc L, Prodisc C Vivo |
| Globus Medical, INC. | $185.64 | 2021-2025 | Vyrsa V1 |
| Cumberland Pharmaceuticals, INC. | $162.43 | 2024 | Caldolor |
| Nevro Corp. | $129.86 | 2022 | |
| Axogen | $128.15 | 2021 | |
| Cerapedics INC. | $120.52 | 2022 | |
| Providence Medical Technology, INC. | $92.67 | 2023-2025 | |
| Bioventus LLC | $43.94 | 2023 | Bonescalpel |
| Depuy Synthes Sales INC. | $41.97 | 2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nuvasive, INC. | $37.53 | 2021 | |
| Integra Lifesciences Corporation | $32.36 | 2019 | |
| Biotronik Nro, INC. | $19.98 | 2025 | Prospera |
| Elite Orthopedics, LLC | $19.78 | 2025 | |
| Augmedics INC. | $19.44 | 2025 | Xvision |
| Abbvie INC. | $19.44 | 2024 | |
| Boston Scientific Corporation | $17.34 | 2023 | Wavewriter Alpha Prime 16 |
| Convatec INC. | $16.24 | 2025 | |
| Innovation Technologies INC | $16.23 | 2025 | Irrisept |
| Corelink, LLC | $15.54 | 2021 | |
| Baxter Healthcare | $15.18 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $13.13 | 2023 | Andexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Sylvester listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.